Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

As the U.S. and China rewrite their rules of engagement, the open exchange of scientific research and talent between the two powers is under scrutiny.

The big picture: Experts warn a "decoupling" of the two global powers — unwinding economic and technological dependencies, as well as raising barriers to collaboration — would destabilize the world and put the U.S.'s innovation edge at risk.

"The openness of the U.S. system has been exploited," says Samm Sacks, a fellow at the New America foundation. "Now the question is, 'Is it possible to maintain that openness in a way that’s resilient?'"

Yes, according to a recent report from the JASON program at MITRE Corp. outlining the risks that come with international collaboration on research.

  • The authors report instances of foreign influence in U.S. fundamental research — via coercion, deception and theft of intellectual property.
  • While the picture isn't complete, they write, there is "a developing situation that appears to be worsening and that represents a threat to our fundamental research enterprise and, in the longer run, our economic security and national security."
  • But ultimately the authors conclude the problems can be addressed with existing ethics and disclosure practices, and that "the benefits of openness in research and of the inclusion of talented foreign researchers dictate against measures that would wall off particular areas of fundamental research."

What's happening: Lawmakers recently formed two groups to address — and fight — foreign influence in U.S. research.

There have also been proposals to wall off areas of research from foreign students or to restrict who can come to the U.S. to study in the first place.

  • Such restrictions would be difficult to implement in practice, says Remco Zwetsloot of Georgetown's Center for Security and Emerging Technology, citing AI as an example of a technology that pervades numerous fields, sectors and industries and is composed of different methods and techniques. "Agencies would have to define what they mean by AI — that is in practice a very hard thing to do."
  • It could also hamper American universities' efforts to attract top talent if foreign researchers go to Canada or elsewhere due to U.S. restrictions. "All you achieve as U.S. policy is to drive scientists out of the U.S.," says Zwetsloot.

Meanwhile, China is trying to draw scientists back to the country, and other nations are trying to woo AI talent.

  • So far, they seem to be staying. Zwetsloot found more than 90% of Chinese students who receive AI-related PhDs from American programs, for example, remain in the U.S. for at least five years.

The bottom line: A true decoupling that gives the U.S. no visibility into technological advancement in China could be "really dangerous," says New America's Sacks.

"Gene-editing? AI? These are technologies that are going to fundamentally change society, and if China and the U.S. go down completely different paths here, there could be dire consequences for humanity," she says.

But, but, but: "One reason not to fear imminent decoupling is that, even at its most successful, China’s model of technological development can proceed only so fast," the Economist writes in its latest issue. "When a technology is complex and expensive, progress is slow, as is shown in the manufacture of semiconductors."

Go deeper:

Editor's note: This story has been updated to specify that MITRE's JASON program wrote the report discussed.

Go deeper

7 hours ago - Health

Biden says it's "not the time to relax" after touring vaccination site

President Biden speaking after visiting a FEMA Covid-19 vaccination facility in Houston on Feb. 26. Photo: Mandel Ngan/AFP via Getty Images

President Biden said Friday that "it's not the time to relax" coronavirus mitigation efforts and warned that the number of cases and hospitalizations could rise again as new variants of the virus emerge.

Why it matters: Biden, who made the remarks after touring a vaccination site in Houston, echoed CDC director Rochelle Walensky, who said earlier on Friday that while the U.S. has seen a recent drop in cases and hospitalizations, "these declines follow the highest peak we have experienced in the pandemic."

Updated 7 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: Most COVID-19 survivors can weather risk of reinfection, study says — "Twindemic" averted as flu reports plummet amid coronavirus crisis
  2. Vaccine: FDA advisory panel endorses J&J COVID vaccine for emergency use — About 20% of U.S. adults have received first vaccine dose, White House says — New data reignites the debate over coronavirus vaccine strategy.
  3. Economy: What's really going on with the labor market.
  4. Local: All adult Minnesotans will likely be eligible for COVID-19 vaccine by summer — Another wealthy Florida community receives special access to COVID-19 vaccine.
  5. Sports: Poll weighs impact of athlete vaccination.

The week markets went wild

Illustration: Lazaro Gamio

The markets just closed out a manic week.

Why it matters: Outsized — and in some cases historic — moves were evident across the board.